Navigation Links
Texas Girl Recovers From Rabies Without Intensive Care
Date:2/25/2010

Natural defense against the disease could be more common than thought, experts say,,

THURSDAY, Feb. 25 (HealthDay News) -- The seemingly miraculous recovery from rabies of a 17-year-old Texas girl -- diagnosed months after a suspected bat bite -- is leaving doctors scratching their heads and wondering if such cases might be less rare than is believed.

The case "suggests the rare possibility that abortive rabies can occur in humans and might go unrecognized," write a team of researchers reporting in this week's issue of Morbidity and Mortality Weekly Report, a publication of the U.S. Centers for Disease and Control and Prevention.

As noted in the report, rabies -- typically transferred to humans via the bites of infected animals such as dogs, raccoons or bats -- is largely fatal if left untreated, and only six such patients have been known to survive worldwide.

In late February of 2009, the girl in question was brought to a Texas hospital, disoriented and in serious pain. She received treatment and within three days her symptoms cleared up and she was sent home. On March 6, however, she was admitted to another hospital with severe headache, rash and weakness in the limbs. This time, she received a diagnosis of encephalitis -- swelling of the brain. She received a barrage of drugs including the antiviral acyclovir (Zovirax) and the antibacterial drug isoniazid (Nydrazid).

However, by March 10 the girl became sicker, weaker and "combative," wrote the team led by Dr. Galit Holzmann-Pazgal, an assistant professor of pediatrics at the University of Texas School of Medicine, in Houston. At this time, the girl mentioned that she had been brushed by flying bats in a cave during a hiking trip more than two months earlier, although she did not recall being bitten.

Tests performed the next day showed antibodies to the rabies virus and on March 14 the girl received one dose of rabies vaccine. She did not get the full round of doses because it was feared it would spur a dangerous immune response.

During all of this, the patient did not require intensive care. In fact, her symptoms resolved so well that she was discharged on March 22. She subsequently returned (on an outpatient basis) complaining of headache on March 29 and then again on April 3. But the headaches went away and she has not since needed hospital care.

This case of "abortive" human rabies appears to be a first, the researchers said. They noted that her illness seemed to follow the typical rabies pattern: An acute encephalopathy about two months after bat exposure is about right for the virus' known incubation period. The girl's symptoms also seemed compatible with rabies, as well, and no other diagnosis appears plausible.

And yet, unlike typical human rabies, in this case "the clinical manifestation was relatively mild," suggesting "more limited" viral spread and "less apparent stimulation of the immune system," according to an editorial comment in the journal. Along with the researchers, the editorial speculates that, in rare cases, humans might develop a mild form of rabies infection from which recovery without intensive care might be possible.

More information

Learn the warning signs of rabies at the U.S. Centers for Disease Control and Prevention.



-- E.J. Mundell



SOURCE: Feb. 26, 2010, Morbidity and Mortality Weekly Report


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Texas-based consortium announces groundbreaking vaccine research program
2. Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 60,300 Square Foot Medical Office Building in Sugar Land, Texas
3. Ongoing Toyota Recall Holds Serious Liability Implications For Manufacturer, but Consumers Must Be Protected, Says Texas Attorney Brad T. Wyly
4. Premier Anesthesia Forges New Partnership with Texas Hospital
5. US Oncology Honored by Texas Governor Perrys Office with Inaugural Governors Business Hall of Fame Award
6. ANT+ and Texas Instruments connect proven ultra low power sensors to smartphones
7. Not Guilty - Texas Jury Acquits Winkler County Nurse
8. New Report: $1 Cigarette Tax Increase Would Raise $418.8 Million for Texas and Cut Youth Smoking
9. Texas Health Dallas Launches Screening Program for Female Heart Disease
10. Saddle Up for a Healthier Trip to the Rodeo! BMI of Texas Offers Healthy Eating Advice for Rodeo-bound Texans
11. Pivot Networks and Brookside Technology Partners, Inc. Team to Broaden Managed IT Services Offering for Texas SMBs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: